The American Academy of Microbiology, a leadership group within the American Society for Microbiology (ASM), has elected UHCOP Professor Vincent H. Tam, Pharm.D., FIDSA, FIDP, BCIDP, to the Fellowship Class of 2026.
For the second consecutive year, the UHCOP Chapter of the Student Society of Health-System Pharmacists (SSHP) has been recognized as a 2025-26 American Society of Health-System Pharmacy (ASHP) Outstanding Professional Development Award recipient for its Residency Bootcamp. The chapter was one of 17 nationwide to receive the honor from the ASHP Pharmacy Student Forum.
UHCOP faculty researcher Anirban Roy, Ph.D., has received a $300,000 grant from the Muscular Dystrophy Association to support his work focusing on Transforming Growth Factor-β–Activated Kinase 1 (TAK1), a signaling protein known to regulate inflammation, muscle growth and cell survival, in the development and progression of Duchenne muscular dystrophy (DMD).
Gao and team developed Nano-273, a dual-function nanodrug packaged in a tiny albumin-based particle, which both activates STING and blocks PI3Kγ—a pathway that drives Breg expansion, while albumin nanoparticles help deliver the drug directly to immune cells, reducing unwanted side effects.
For the second consecutive year, the UHCOP Chapter of the Student Society of Health-System Pharmacists (SSHP) has been recognized as a 2025-26 American Society of Health-System Pharmacy (ASHP) Outstanding Professional Development Award recipient for its Residency Bootcamp. The chapter was one of 17 nationwide to receive the honor from the ASHP Pharmacy Student Forum.
The American Academy of Microbiology, a leadership group within the American Society for Microbiology (ASM), has elected UHCOP Professor Vincent H. Tam, Pharm.D., FIDSA, FIDP, BCIDP, to the Fellowship Class of 2026.
Addressing a growing demand for graduate training in evaluating medication safety, effectiveness and outcomes in real-world clinical settings, UHCOP is expanding its offerings within the Pharmaceutical Sciences graduate program. The college will now offer a Master of Science and a doctoral degree in Population Health & Pharmacoepidemiology.
Pharm.D. candidate Chad Johnson’s journey to pharmacy was shaped by early clinical experiences, strong mentorship and a passion for patient-centered care. From excelling in leadership and clinical competitions to impactful rotations in critical care and cardiology, Johnson has distinguished himself academically, professionally and through research.
Professor Mingfu Wu, Ph.D., and recent graduate Anika Nusrat, Ph.D., have identified a new cause of — and repair for — left ventricular non-compaction, also known as spongy heart disease. The new therapeutic approach, performed in utero, may prevent babies from being born with this life-threatening disease, which often causes the dire need for a heart transplant.
UHCOP Pharm.D. candidate Tam Vu shares how family, education and hands-on community outreach shaped his path to pharmacy and why building trust and long-term relationships with patients matters most to him.